Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

ZNO

  • Home
  •  
  • ZNO



  • Most Read
  • Latest Comments
  • Zoono and OSY team up to tackle food waste in exclusive agreement
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Zoono and OSY team up to tackle food waste in exclusive agreement
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Zoono and OSY team up to tackle food waste in exclusive agreement
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Zoono and OSY team up to tackle food waste in exclusive agreement
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Zoono and OSY team up to tackle food waste in exclusive agreement
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

  • Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    • News

  • Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial
    Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial
    • News

  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    Arovella completes development for cell therapy platform, moves to large scale manufacturing
    • News

  • Zoono and OSY team up to tackle food waste in exclusive agreement
    • News

    Zoono and OSY team up to tackle food waste in exclusive agreement

    Despite global efforts, food waste remains a challenging problem to solve. Each year, 1.3 billion tons of food is wasted due to poor handling, costing the global economy $1.5 trillion. This waste contributes 6-8% of annual greenhouse gas emissions and, what’s more, if saved, it could have fed about 1.26 billion people. No doubt, food

    Read More
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets

    The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive

    Read More
    Public
  • The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?

    Who said capitalism was dead in the new world order of prolific government handouts? The profit motive is at least alive and kicking in the sexed-up sanitiser sector, as both new and established participants grab on to what’s hopefully a once-in-a-lifetime opportunity. For consumers, it’s a case of “you can’t be serious” as they scour

    Read More
    Public
  • Zoono successfully tests against coronavirus COVID-19, shares skyrocket
    • News

    Zoono successfully tests against coronavirus COVID-19, shares skyrocket

    Biotech company Zoono Group (ASX: ZNO) has reported that its lab tests against COVID-19 have shown their hand sanitiser product to have more than 99.99% efficacy in deactivating the coronavirus pathogens.  Conducted under strict European testing standards, the tests conducted identified Zoono’s Z-71 Microbe Shield hand sanitiser to be effective against a variety of pathogens

    Read More
    Public
  • Zoono secures Chinese distributor after impressive African swine fever trials
    • News

    Zoono secures Chinese distributor after impressive African swine fever trials

    With China having lost more than 100 million pigs due to the recent outbreak of African swine fever in the mainland, attention has been thrust upon preventative measures, leading a Chinese Group to engage chemical company Zoono (ASX: ZNO) for a 10-year distribution arrangement.  The Chinese Group will use the Zoono China brand to sell

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.